The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

JP Armand, AK Burnett, J Drach, JL Harousseau, Bob Löwenberg, JS Miguel

Research output: Contribution to journal › Article › Academic

34 Citations (Scopus)

Research programs

@article{70c907ad0e5e4395ad79daae4c6885b4,

title = "The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib",

author = "JP Armand and AK Burnett and J Drach and JL Harousseau and Bob L{\"o}wenberg and JS Miguel",

year = "2007",

doi = "10.1634/theoncologist.12-3-281",

language = "Undefined/Unknown",

volume = "12",

pages = "281--290",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

AU - Armand, JP

AU - Burnett, AK

AU - Drach, J

AU - Harousseau, JL

AU - Löwenberg, Bob

AU - Miguel, JS

PY - 2007

Y1 - 2007

U2 - 10.1634/theoncologist.12-3-281

DO - 10.1634/theoncologist.12-3-281

M3 - Article

C2 - 17405892

SN - 1083-7159

VL - 12

SP - 281

EP - 290

JO - Oncologist

JF - Oncologist

IS - 3

ER -